An example of the use of this approach is biodegradable PLGA nanoparticles loaded with myelin oligodendrocyte glycoprotein (MOG) peptides, which has shown efficacy in models of multiple sclerosis mediated by immune tolerance. The gene discussed is MOG; the disease is multiple sclerosis.